Copertina

Repeated Intake of Grapefruit Juice Inhibits CYP2B6 , CYP2C9 , CYP2C19 , and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Laura Aurinsalo, Outi Lapatto‐Reiniluoto, Mika Kurkela, Mikko Neuvonen, Eeva Moilanen, Mikko Niemi, Aleksi Tornio, Janne T. Backman
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil
di: Laura Aurinsalo, et al.
Pubblicazione: (2025)

Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function
di: Kreetta Hämäläinen, et al.
Pubblicazione: (2024)

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants
di: Jason D. Kim, et al.
Pubblicazione: (2026)

Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population
di: Carolina Céspedes-Garro
Pubblicazione: (2016)

Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study
di: Rachel Conyers, et al.
Pubblicazione: (2025)

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
di: Danwei Shao, et al.
Pubblicazione: (2026)

Frequency of Key Pharmacogenes CYP2C9 , CYP2C19 , CYP2D6 , and SLCO1B1 in the Yogyakarta Population: Implications for Precision Prescribing in Indonesia
di: Dwi Aris Agung Nugrahaningsih, et al.
Pubblicazione: (2026)

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
di: Sylvia D. Klomp, et al.
Pubblicazione: (2024)

Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems
di: Janne T. Backman
Pubblicazione: (2025)

Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects
di: Shuaibing Liu, et al.
Pubblicazione: (2024)

Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure
di: Luke Fostvedt, et al.
Pubblicazione: (2024)

Farmacogenómica clínica de CYP2C8 y CYP2C9: conceptos generales y aplicación al uso de AINE
di: C. Martínez
Pubblicazione: (2006)

Estudio de las variantes alélicas CYP2C9*2 y CYP2C9*3 en muestras de población mestiza peruana
di: Ángel Tito Alvarado
Pubblicazione: (2019)

Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants
di: Shichang Miao, et al.
Pubblicazione: (2024)

Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain
di: Ana Casajús, et al.
Pubblicazione: (2024)

Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
di: Sherouk M. Okda, et al.
Pubblicazione: (2024)

Food‐derived compounds for CYP‐phenotyping
di: Manuel Haschke
Pubblicazione: (2024)

Use ofCYP2D6Inhibitors withCYP2D6Opioids: Association with Emergency Department Visits for Pain
di: Noor Ahmed Nahid, et al.
Pubblicazione: (2024)

Effect of chlorpyrifos‐exposure on the expression levels of CYP genes in Daphnia magna and examination of a possibility that an up‐regulated clan 3 CYP, CYP360A8, reacts with pesticides
di: Shinpei Ohnuki, et al.
Pubblicazione: (2024)

Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms
di: Xiaomei I. Liu, et al.
Pubblicazione: (2024)

Effect of CYP2C9 Polymorphism on Neuropsychiatric Symptoms in Alzheimer’s Dementia
di: Evelyn Gutiérrez, et al.
Pubblicazione: (2024)

Evaluation of Potential Effects of CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Fruquintinib in Healthy Subjects
di: Martha Gonzalez, et al.
Pubblicazione: (2025)

PharmVar GeneFocus: CYP4F2
di: Pablo Zubiaur, et al.
Pubblicazione: (2024)

Impact of CYP2D6 genotype on fluoxetine exposure
di: Y. W. Francis Lam
Pubblicazione: (2025)

Pregnane X receptor activation induces liver enlargement and regeneration and simultaneously promotes the metabolic activity of CYP3A1/2 and CYP2C6/11 in rats
di: Guofang Bi, et al.
Pubblicazione: (2024)

Influence of novel CYP2C‐haplotype on proton pump inhibitor pharmacokinetics in children
di: Kathryn E. Kyler, et al.
Pubblicazione: (2024)

Genetic variations in CYP2A6, CYP2E1, GSTM1, GSTT1 genes and the risk of Nasopharyngeal carcinoma in North African population
di: Imane EL Alami, et al.
Pubblicazione: (2024)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
di: Eugene Jeong, et al.
Pubblicazione: (2025)

Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
di: Lucy Lee, et al.
Pubblicazione: (2024)

CYP1A1, CYP2E1 Y RIESGO A CÁNCER GÁSTRICO EN UNA POBLACIÓN COLOMBIANA DE ALTA INCIDENCIA
di: EDUARDO CASTAÑO-MOLINA
Pubblicazione: (2009)

MYB47 delays leaf senescence by modulating jasmonate pathway via direct regulation of CYP94B3 / CYP94C1 expression in Arabidopsis
di: Jie Cao, et al.
Pubblicazione: (2025)

Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Pubblicazione: (2024)

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
di: Kenza Abouir, et al.
Pubblicazione: (2024)

CYP1A1, CYP1B1, GSTM1 and GSTT1 genetic variants and breast cancer risk in Mexican women
di: Angélica García-Martínez
Pubblicazione: (2017)

CYP2D6 Copy Number Variations Identified by KASP PCR
di: Steffen Jørgensen, et al.
Pubblicazione: (2025)

Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans
di: Carolina Céspedes-Garro
Pubblicazione: (2014)

Retracted: Compound Shuganjieyu Capsule on CYP450 Enzyme Activity
di: BioMed Research International
Pubblicazione: (2024)

CYP2C19 Genotype is Associated with Citalopram Treatment Outcomes in a Real‐World Setting
di: Yoomi Park, et al.
Pubblicazione: (2026)

Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions of Soticlestat as a Victim of CYP Induction and Inhibition, and as a Perpetrator of CYP and P–Glycoprotein Inhibition
di: Hongxia Jia, et al.
Pubblicazione: (2025)

Association Between CYP2D6 Genotypes and Serum Concentrations of Mirtazapine and Mianserin
di: Kristine Hole, et al.
Pubblicazione: (2025)